Tasly Pharmaceutical Group Co Ltd (600535) — Financial Flexibility Index
Tasly Pharmaceutical Group Co Ltd (600535) has a Financial Flexibility Index of 0.24x as of December 2025. Free cash flow of CN¥669.91 Million (operating CF CN¥552.13 Million minus capex CN¥117.78 Million) represents 0% of total liabilities (CN¥2.79 Billion). Also explore Tasly Pharmaceutical Group Co Ltd (600535) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tasly Pharmaceutical Group Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Tasly Pharmaceutical Group Co Ltd across 25 annual periods. Check Tasly Pharmaceutical Group Co Ltd (600535) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tasly Pharmaceutical Group Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Tasly Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Tasly Pharmaceutical Group Co Ltd (600535) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | CN¥1.81 Billion | CN¥1.42 Billion | CN¥2.79 Billion | ▼ -28.2% |
| 2024 | 0.90x | CN¥2.58 Billion | CN¥2.01 Billion | CN¥2.87 Billion | ▲ +11.7% |
| 2023 | 0.81x | CN¥3.24 Billion | CN¥2.58 Billion | CN¥4.02 Billion | ▲ +13.9% |
| 2022 | 0.71x | CN¥2.69 Billion | CN¥2.29 Billion | CN¥3.80 Billion | ▼ -32.3% |
| 2021 | 1.04x | CN¥3.37 Billion | CN¥2.80 Billion | CN¥3.23 Billion | ▲ +95.2% |
| 2020 | 0.54x | CN¥2.20 Billion | CN¥1.79 Billion | CN¥4.11 Billion | ▲ +169.8% |
| 2019 | 0.20x | CN¥2.41 Billion | CN¥1.68 Billion | CN¥12.15 Billion | ▲ +21.9% |
| 2018 | 0.16x | CN¥2.27 Billion | CN¥1.49 Billion | CN¥13.96 Billion | ▲ +757.5% |
| 2017 | -0.02x | CN¥-310.99 Million | CN¥-822.56 Million | CN¥12.56 Billion | ▼ -113.2% |
| 2016 | 0.19x | CN¥1.68 Billion | CN¥1.15 Billion | CN¥8.92 Billion | ▲ +34.5% |
| 2015 | 0.14x | CN¥1.08 Billion | CN¥340.00 Million | CN¥7.71 Billion | ▼ -19.9% |
| 2014 | 0.17x | CN¥1.37 Billion | CN¥616.76 Million | CN¥7.85 Billion | ▲ +5.0% |
| 2013 | 0.17x | CN¥1.01 Billion | CN¥346.17 Million | CN¥6.07 Billion | ▼ -32.1% |
| 2012 | 0.24x | CN¥803.33 Million | CN¥413.31 Million | CN¥3.28 Billion | ▲ +25.5% |
| 2011 | 0.20x | CN¥557.71 Million | CN¥135.14 Million | CN¥2.86 Billion | ▼ -29.5% |
| 2010 | 0.28x | CN¥561.18 Million | CN¥395.05 Million | CN¥2.03 Billion | ▼ -0.8% |
| 2009 | 0.28x | CN¥517.19 Million | CN¥400.39 Million | CN¥1.85 Billion | ▲ +0.9% |
| 2008 | 0.28x | CN¥374.72 Million | CN¥260.21 Million | CN¥1.36 Billion | ▼ -26.8% |
| 2007 | 0.38x | CN¥422.78 Million | CN¥221.55 Million | CN¥1.12 Billion | ▲ +46.8% |
| 2006 | 0.26x | CN¥395.97 Million | CN¥140.56 Million | CN¥1.54 Billion | ▼ -40.2% |
| 2005 | 0.43x | CN¥511.22 Million | CN¥214.90 Million | CN¥1.19 Billion | ▼ -38.0% |
| 2004 | 0.69x | CN¥572.88 Million | CN¥203.27 Million | CN¥826.42 Million | ▲ +2.9% |
| 2003 | 0.67x | CN¥387.74 Million | CN¥59.00 Million | CN¥575.74 Million | ▼ -48.6% |
| 2002 | 1.31x | CN¥332.31 Million | CN¥206.22 Million | CN¥253.70 Million | ▲ +124.5% |
| 2001 | 0.58x | CN¥203.12 Million | CN¥83.77 Million | CN¥348.19 Million | — |